Steroid-sensitive Gene 1 Is a Novel Cyclic GMP-dependent Protein Kinase I Substrate in Vascular Smooth Muscle Cells
NO, via its second messenger cGMP, activates protein kinase GI (PKGI) to induce vascular smooth muscle cell relaxation. The mechanisms by which PKGI kinase activity regulates cardiovascular function remain incompletely understood. Therefore, to identify novel protein kinase G substrates in vascular...
Saved in:
Published in | The Journal of biological chemistry Vol. 288; no. 34; pp. 24972 - 24983 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
23.08.2013
American Society for Biochemistry and Molecular Biology |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | NO, via its second messenger cGMP, activates protein kinase GI (PKGI) to induce vascular smooth muscle cell relaxation. The mechanisms by which PKGI kinase activity regulates cardiovascular function remain incompletely understood. Therefore, to identify novel protein kinase G substrates in vascular cells, a λ phage coronary artery smooth muscle cell library was constructed and screened for phosphorylation by PKGI. The screen identified steroid-sensitive gene 1 (SSG1), which harbors several predicted PKGI phosphorylation sites. We observed direct and cGMP-regulated interaction between PKGI and SSG1. In cultured vascular smooth muscle cells, both the NO donor S-nitrosocysteine and atrial natriuretic peptide induced SSG1 phosphorylation, and mutation of SSG1 at each of the two predicted PKGI phosphorylation sites completely abolished its basal phosphorylation by PKGI. We detected high SSG1 expression in cardiovascular tissues. Finally, we found that activation of PKGI with cGMP regulated SSG1 intracellular distribution.
Background: Protein kinase GI (PKGI) regulates multiple cardiovascular processes, but its effectors remain incompletely understood.
Results: We identified steroid-sensitive gene 1 (SSG1) as being regulated by PKG in vascular cells.
Conclusion: SSG1 functions as a PKGI kinase target and interacting partner in cardiovascular tissues.
Significance: Identifying new PKGI effectors may improve the understanding of the pathophysiology of cardiovascular diseases. |
---|---|
Bibliography: | Present address: Sanofi-Aventis, 55 Corporate Dr., Bridgewater, NJ 08807. Present address: Merck & Co., Inc., One Merck Dr., Whitehouse Station, NJ 08889. Present address: Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065. |
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M113.456244 |